6:25 PM
 | 
Dec 12, 2012
 |  BC Extra  |  Top Story

Gilead to acquire YM BioSciences

Gilead Sciences Inc. (NASDAQ:GILD) will acquire YM BioSciences Inc. (TSX:YM; NYSE-M:YMI) for $2.95 per share, or about $510.3 million based on 173 million fully diluted YM shares. The price...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >